Consistent with these findings, peripheral administration of leptin has also been shown to alleviate hyperketonemia [35,38], hyperglucagonemia [20,39], and hypercorticosteronemia [20,39] in IDDM rodent models. This evidence concerns the gene LEP and type 1 diabetes mellitus.